Using claims data linked with electronic health records to monitor and improve adherence to medication

J. M. Lobo, B. T. Denton, J. R. Wilson, Nilay D Shah, S. A. Smith

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Poor adherence to medication is a serious problem in the United States, leading to complications and preventable hospitalizations, particularly for patients with chronic diseases. Interventions have been proposed as a means to improve adherence to medication, but the optimal time to perform an intervention has not been well studied. We provide a use case for how claims data linked with electronic health records (EHRs) can be used to monitor patient adherence to medication and provide a source of information to help decide when to perform an intervention. We propose a Markov decision process (MDP) model to determine when to perform adherence-improving interventions based on a patient’s EHR. We consider the the societal perspective where we trade off maximization of time to first adverse health event and minimization of cost of interventions, medication, and adverse events. We use our model to evaluate the costs and benefits of implementing an EHR-based active surveillance system for adherence-improving interventions in the context of cardiovascular disease management for patients with type 2 diabetes. We also provide some theoretical insights into the structure of the optimal intervention policy and the influence of health risks and costs on intervention decisions.

Original languageEnglish (US)
Pages (from-to)194-214
Number of pages21
JournalIISE Transactions on Healthcare Systems Engineering
Volume7
Issue number4
DOIs
StatePublished - Oct 2 2017

Fingerprint

Medication Adherence
Electronic Health Records
medication
Health
electronics
health
Markov Chains
Patient Compliance
Disease Management
Costs
Health Care Costs
Type 2 Diabetes Mellitus
Cost-Benefit Analysis
Health risks
Hospitalization
Chronic Disease
Cardiovascular Diseases
Medical problems
Costs and Cost Analysis
costs

Keywords

  • Claims data
  • electronic health records
  • intervention
  • Markov decision process
  • medication adherence

ASJC Scopus subject areas

  • Safety, Risk, Reliability and Quality
  • Safety Research
  • Public Health, Environmental and Occupational Health

Cite this

Using claims data linked with electronic health records to monitor and improve adherence to medication. / Lobo, J. M.; Denton, B. T.; Wilson, J. R.; Shah, Nilay D; Smith, S. A.

In: IISE Transactions on Healthcare Systems Engineering, Vol. 7, No. 4, 02.10.2017, p. 194-214.

Research output: Contribution to journalArticle

@article{03c360f3311d46b3af80a59f14a129aa,
title = "Using claims data linked with electronic health records to monitor and improve adherence to medication",
abstract = "Poor adherence to medication is a serious problem in the United States, leading to complications and preventable hospitalizations, particularly for patients with chronic diseases. Interventions have been proposed as a means to improve adherence to medication, but the optimal time to perform an intervention has not been well studied. We provide a use case for how claims data linked with electronic health records (EHRs) can be used to monitor patient adherence to medication and provide a source of information to help decide when to perform an intervention. We propose a Markov decision process (MDP) model to determine when to perform adherence-improving interventions based on a patient’s EHR. We consider the the societal perspective where we trade off maximization of time to first adverse health event and minimization of cost of interventions, medication, and adverse events. We use our model to evaluate the costs and benefits of implementing an EHR-based active surveillance system for adherence-improving interventions in the context of cardiovascular disease management for patients with type 2 diabetes. We also provide some theoretical insights into the structure of the optimal intervention policy and the influence of health risks and costs on intervention decisions.",
keywords = "Claims data, electronic health records, intervention, Markov decision process, medication adherence",
author = "Lobo, {J. M.} and Denton, {B. T.} and Wilson, {J. R.} and Shah, {Nilay D} and Smith, {S. A.}",
year = "2017",
month = "10",
day = "2",
doi = "10.1080/24725579.2017.1346728",
language = "English (US)",
volume = "7",
pages = "194--214",
journal = "IISE Transactions on Healthcare Systems Engineering",
issn = "2472-5579",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Using claims data linked with electronic health records to monitor and improve adherence to medication

AU - Lobo, J. M.

AU - Denton, B. T.

AU - Wilson, J. R.

AU - Shah, Nilay D

AU - Smith, S. A.

PY - 2017/10/2

Y1 - 2017/10/2

N2 - Poor adherence to medication is a serious problem in the United States, leading to complications and preventable hospitalizations, particularly for patients with chronic diseases. Interventions have been proposed as a means to improve adherence to medication, but the optimal time to perform an intervention has not been well studied. We provide a use case for how claims data linked with electronic health records (EHRs) can be used to monitor patient adherence to medication and provide a source of information to help decide when to perform an intervention. We propose a Markov decision process (MDP) model to determine when to perform adherence-improving interventions based on a patient’s EHR. We consider the the societal perspective where we trade off maximization of time to first adverse health event and minimization of cost of interventions, medication, and adverse events. We use our model to evaluate the costs and benefits of implementing an EHR-based active surveillance system for adherence-improving interventions in the context of cardiovascular disease management for patients with type 2 diabetes. We also provide some theoretical insights into the structure of the optimal intervention policy and the influence of health risks and costs on intervention decisions.

AB - Poor adherence to medication is a serious problem in the United States, leading to complications and preventable hospitalizations, particularly for patients with chronic diseases. Interventions have been proposed as a means to improve adherence to medication, but the optimal time to perform an intervention has not been well studied. We provide a use case for how claims data linked with electronic health records (EHRs) can be used to monitor patient adherence to medication and provide a source of information to help decide when to perform an intervention. We propose a Markov decision process (MDP) model to determine when to perform adherence-improving interventions based on a patient’s EHR. We consider the the societal perspective where we trade off maximization of time to first adverse health event and minimization of cost of interventions, medication, and adverse events. We use our model to evaluate the costs and benefits of implementing an EHR-based active surveillance system for adherence-improving interventions in the context of cardiovascular disease management for patients with type 2 diabetes. We also provide some theoretical insights into the structure of the optimal intervention policy and the influence of health risks and costs on intervention decisions.

KW - Claims data

KW - electronic health records

KW - intervention

KW - Markov decision process

KW - medication adherence

UR - http://www.scopus.com/inward/record.url?scp=85028527519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028527519&partnerID=8YFLogxK

U2 - 10.1080/24725579.2017.1346728

DO - 10.1080/24725579.2017.1346728

M3 - Article

AN - SCOPUS:85028527519

VL - 7

SP - 194

EP - 214

JO - IISE Transactions on Healthcare Systems Engineering

JF - IISE Transactions on Healthcare Systems Engineering

SN - 2472-5579

IS - 4

ER -